Literature DB >> 15104673

A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3,4,5.

D C Sayer1, R Whidborne, D De Santis, E H Rozemuller, F T Christiansen, M G Tilanus.   

Abstract

We have described previously a novel single-tube polymerase chain reaction (PCR) amplification (STAmp) protocol for the efficient sequencing-based typing (SBT) of human leukocyte antigen (HLA)-DRB1. The PCR amplification mix includes primers to each of seven allele group-sequence motifs. We have applied this principle to the simultaneous SBT of HLA-DRB3, -DRB4, and -DRB5 using locus specific primers. We report here a multicenter international evaluation of the STAmp protocols performed as a component of the 13th International Histocompatibility Workshop. Identical amplification primer mixes, sequencing primers, and DNA were sent to participating laboratories. The primer mixes contained the amplification primers and the PCR buffer. Each laboratory was requested to amplify the DNA with the primer mixes and perform SBT on the resulting PCR protocols, using their own protocols, and return the typing results for analysis. The reported results indicated that the expected sequence could be obtained with a variety of PCR amplification and sequencing platforms and protocols. There were difficulties but these seemed unrelated to STAmp reagents and suggest that optimal SBT results can be obtained if bi-directional sequencing is performed and software is used for sequence verification and editing. This indicates that SBT by STAmp can be applied in many laboratories for high-throughput HLA-DRB1 and HLA-DRB3,4,5 SBT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104673     DOI: 10.1111/j.0001-2815.2004.00214.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  14 in total

1.  Population-specific recombination sites within the human MHC region.

Authors:  T H Lam; M Shen; J-M Chia; S H Chan; E C Ren
Journal:  Heredity (Edinb)       Date:  2013-05-29       Impact factor: 3.821

2.  Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk.

Authors:  Jia Nee Foo; Karin E Smedby; Nicholas K Akers; Mattias Berglund; Ishak D Irwan; Xiaoming Jia; Yi Li; Lucia Conde; Hatef Darabi; Paige M Bracci; Mads Melbye; Hans-Olov Adami; Bengt Glimelius; Chiea Chuen Khor; Henrik Hjalgrim; Leonid Padyukov; Keith Humphreys; Gunilla Enblad; Christine F Skibola; Paul I W de Bakker; Jianjun Liu
Journal:  Am J Hum Genet       Date:  2013-06-20       Impact factor: 11.025

3.  Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study.

Authors:  Benedicte A Lie; Marte K Viken; Sigrid Odegård; Désirée van der Heijde; Robert Landewé; Till Uhlig; Tore K Kvien
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

4.  Increased risk of strontium ranelate-related SJS/TEN is associated with HLA.

Authors:  H Y Lee; M X Shen; Y L Lim; Y K Tay; M M F Chan; S M Pang; Z W Xiao; S B Ang; E C Ren
Journal:  Osteoporos Int       Date:  2016-03-22       Impact factor: 4.507

5.  Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis.

Authors:  Marcus Ronninger; Maria Seddighzadeh; Morten Christoph Eike; Darren Plant; Nina A Daha; Beate Skinningsrud; Jane Worthington; Tore K Kvien; Rene E M Toes; Benedicte A Lie; Lars Alfredsson; Leonid Padyukov
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

6.  Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population.

Authors:  Angelina H Maniaol; Ahmed Elsais; Åslaug R Lorentzen; Jone F Owe; Marte K Viken; Hanne Sæther; Siri T Flåm; Geir Bråthen; Margitta T Kampman; Rune Midgard; Marte Christensen; Anna Rognerud; Emilia Kerty; Nils Erik Gilhus; Chantal M E Tallaksen; Benedicte A Lie; Hanne F Harbo
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

7.  Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis.

Authors:  Jenny Link; Ingrid Kockum; Aslaug R Lorentzen; Benedicte A Lie; Elisabeth G Celius; Helga Westerlind; Marie Schaffer; Lars Alfredsson; Tomas Olsson; Boel Brynedal; Hanne F Harbo; Jan Hillert
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

8.  Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.

Authors:  Inger-Lise Mero; Marte W Gustavsen; Hanne S Sæther; Siri T Flåm; Pål Berg-Hansen; Helle B Søndergaard; Poul Erik H Jensen; Tone Berge; Anja Bjølgerud; Aslaug Muggerud; Jan H Aarseth; Kjell-Morten Myhr; Elisabeth G Celius; Finn Sellebjerg; Jan Hillert; Lars Alfredsson; Tomas Olsson; Annette Bang Oturai; Ingrid Kockum; Benedicte A Lie; Bettina Kulle Andreassen; Hanne F Harbo
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

9.  The genetic variants at the HLA-DRB1 gene are associated with primary IgA nephropathy in Han Chinese.

Authors:  Yang Jiyun; Li Guisen; Zhu Li; Shi Yi; Lv Jicheng; Lu Fang; Liu Xiaoqi; Ma Shi; Jing Cheng; Lin Ying; Wang Haiyan; Wang Li; Zhang Hong; Yang Zhenglin
Journal:  BMC Med Genet       Date:  2012-05-14       Impact factor: 2.103

10.  HLA-B*1301 as a biomarker for genetic susceptibility to hypersensitivity dermatitis induced by trichloroethylene among workers in China.

Authors:  Haishan Li; Yufei Dai; Hanlin Huang; Laiyu Li; Shuguang Leng; Juan Cheng; Yong Niu; Huawei Duan; Qingjun Liu; Xing Zhang; Xianqing Huang; Jinxin Xie; Zhiming Feng; Juncai Wang; Jiaxi He; Yuxin Zheng
Journal:  Environ Health Perspect       Date:  2007-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.